検索結果

r frequencies with the new formulation. Therefore, the new formulation is expected to contribute to improved adherence among glaucoma patients while ensuring safe and reliable use. About Glaucoma Glau...

Research and Development System | Research & Development | SENJU Pharmaceutica

utional Animal Care and Use Committee conducts a self-audit at least once a year aiming for further improvements. Our research facility, the Kobe Innovative Center, has been accredited by AAALAC Inter...

ith a system specialized for the ophthalmology field. This OptiLight M22 IPL Model is indicated for improvement of symptoms of Dry Eye Disease due to MGD (Meibomian Gland Dysfunction ), and was previo...

CEO Message | About Senju | SENJU Pharmaceutical

ting to change.Our wish is to continue to be trusted by society as we contribute to the support and improvement of patients’ Quality of Vision around the world by continuously creating and proposing r...

Compliance System | Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical

ity and products that bring health benefits to the lives of the public, thereby contributing to the improvement of the lives and health of all people around the world. To abide by the principles defin...